A straightforward meta‐analysis approach for oncology phase I dose‐finding studies
A straightforward meta‐analysis approach for oncology phase I dose‐finding studies
Phase I early-phase clinical studies aim at investigating the safety and the underlying dose-toxicity relationship of a drug or combination. While little may still be known about the compound's properties, it is crucial to consider quantitative information available from any studies that may have been conducted previously on the same …